IL-15 enhances survival and function of HIV-specific CD8+ T cells

YM Mueller, PM Bojczuk, ES Halstead… - Blood, The Journal …, 2003 - ashpublications.org
YM Mueller, PM Bojczuk, ES Halstead, AHJ Kim, J Witek, JD Altman, PD Katsikis
Blood, The Journal of the American Society of Hematology, 2003ashpublications.org
Abstract HIV-specific CD8+ T cells are prone to undergo apoptosis, and this may affect their
ability to control HIV infection. Because CD8-mediated immune responses play a key role in
controlling HIV infection, enhancing the survival and effector function of HIV-specific CD8+ T
cells may augment their ability to control HIV virus. We show here that interleukin 15 (IL-15)
potently inhibits spontaneous and CD95/Fas-induced apoptosis of HIV-specific CD8+ T
cells. IL-15 inhibits apoptosis in both CD45RA− CD62L− and CD45RA+ CD62L− effector …
Abstract
HIV-specific CD8+ T cells are prone to undergo apoptosis, and this may affect their ability to control HIV infection. Because CD8-mediated immune responses play a key role in controlling HIV infection, enhancing the survival and effector function of HIV-specific CD8+ T cells may augment their ability to control HIV virus. We show here that interleukin 15 (IL-15) potently inhibits spontaneous and CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. IL-15 inhibits apoptosis in both CD45RACD62L and CD45RA+CD62L effector memory subpopulations of these cells. Furthermore, IL-15 greatly enhances the survival of HIV-specific CD8+ T cells in long-term cultures. Finally, IL-15 directly enhances activation, interferon γ (IFNγ) production, and direct ex vivo cytotoxicity of HIV-specific CD8+ T cells. Thus, IL-15 potently enhances the survival and effector function of HIV-specific CD8+ T cells and, therefore, may prove useful in augmenting the antiviral function of these cells.
ashpublications.org